-
EP1442745
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1442745
| EP1442745 - Orally administrable opioid formulations having extended duration of effect [Right-click to bookmark this link] | Status | The application has been refused Status updated on 28.11.2008 Database last updated on 02.11.2024 | Most recent event Tooltip | 28.11.2008 | Change - refusal | published on 31.12.2008 [2009/01] | Applicant(s) | For all designated states EURO-CELTIQUE S.A. 2, avenue Charles de Gaulle 1653 Luxembourg / LU | [2008/23] |
| Former [2004/32] | For all designated states Euro-Celtique 122, boulevard de la Petrusse 2330 Luxembourg / LU | Inventor(s) | 01 /
Oshlack, Benjamin 351 East 84th Street New York, N.Y. 10028 / US | 02 /
Chasin, Mark 3 Turnberry Drive Monroe, NJ 08831 / US | [2004/35] |
| Former [2004/32] | 01 /
Oshlack, Benjamin 351 East 84th Street New York, N.Y. 10028 / US | ||
| 02 /
Chasin, Mark 3 Wayne Court ManaLAPAN, nj 07726 / US | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
| Former [2004/32] | Maiwald Patentanwalts GmbH Elisenhof, Elisenstrasse 3 80335 München / DE | Application number, filing date | 04006971.8 | 30.09.1994 | [2004/32] | Priority number, date | US19930133503 | 07.10.1993 Original published format: US 133503 | [2004/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1442745 | Date: | 04.08.2004 | Language: | EN | [2004/32] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.06.2004 | Classification | IPC: | A61K31/485, A61K9/16, A61K9/50 | [2004/32] | CPC: |
A61K9/1635 (EP,KR);
A61K9/1617 (EP,KR);
A61K31/485 (EP,KR);
A61K31/522 (EP,KR);
A61K9/2077 (EP,KR);
A61K9/2081 (EP,KR);
A61K9/5078 (EP,KR);
A61P23/00 (EP);
A61P25/04 (EP);
A61P29/00 (EP);
A61K9/1623 (EP);
A61K9/5026 (EP);
A61K9/5047 (EP)
(-)
| Designated contracting states | AT, BE, CH, DE, ES, FR, GB, IE, IT, LI, LU, NL, PT, SE [2004/32] | Title | German: | Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung | [2004/32] | English: | Orally administrable opioid formulations having extended duration of effect | [2004/32] | French: | Compositions d'opioides pour administration orale ayant un effet prolongé | [2004/32] | Examination procedure | 23.03.2004 | Examination requested [2004/32] | 28.06.2004 | Amendment by applicant (claims and/or description) | 04.08.2004 | Despatch of a communication from the examining division (Time limit: M04) | 14.10.2004 | Reply to a communication from the examining division | 19.05.2005 | Despatch of a communication from the examining division (Time limit: M04) | 12.07.2005 | Reply to a communication from the examining division | 05.12.2005 | Despatch of a communication from the examining division (Time limit: M04) | 03.04.2006 | Reply to a communication from the examining division | 11.08.2006 | Despatch of a communication from the examining division (Time limit: M06) | 20.02.2007 | Reply to a communication from the examining division | 10.04.2007 | Despatch of a communication from the examining division (Time limit: M04) | 19.07.2007 | Reply to a communication from the examining division | 11.04.2008 | Application refused, date of legal effect [2008/50] | 11.04.2008 | Date of oral proceedings | 16.05.2008 | Minutes of oral proceedings despatched | 28.05.2008 | Despatch of communication that the application is refused, reason: substantive examination [2008/50] | 28.05.2008 | Despatch of communication that the application is refused, reason: substantive examination [2009/01] | 28.05.2008 | Minutes of oral proceedings despatched | 26.09.2008 | Application refused, date of legal effect [2009/01] | Appeal following examination | 29.07.2008 | Appeal received No. T2035/08 | 26.09.2008 | Result of appeal procedure: appeal of the applicant withdrawn | Parent application(s) Tooltip | EP94115465.0 / EP0647448 | Divisional application(s) | EP08165040.0 / EP2036558 | Fees paid | Renewal fee | 23.03.2004 | Renewal fee patent year 03 | 23.03.2004 | Renewal fee patent year 04 | 23.03.2004 | Renewal fee patent year 05 | 23.03.2004 | Renewal fee patent year 06 | 23.03.2004 | Renewal fee patent year 07 | 23.03.2004 | Renewal fee patent year 08 | 23.03.2004 | Renewal fee patent year 09 | 23.03.2004 | Renewal fee patent year 10 | 30.09.2004 | Renewal fee patent year 11 | 05.09.2005 | Renewal fee patent year 12 | 08.09.2006 | Renewal fee patent year 13 | 05.09.2007 | Renewal fee patent year 14 | 05.09.2008 | Renewal fee patent year 15 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0097523 (EURO CELTIQUE SA [LU]) [A] 1-46 * claims 1,3-5,7 * * page 8, line 19 - line 24 * * page 28, line 28 - line 35 * * page 29, line 1 - line 12 *; | [A]EP0253104 (EURO CELTIQUE SA [LU]) [A] 1-46 * claim - * * page 3, line 40 - line 49 * * page 4, line 29 - line 34 * * example II *; | [DA]EP0271193 (EURO CELTIQUE SA [LU]) [DA] 1-46 * claim - * * page 4, line 5 - line 10 * * page 4, line 18 - line 33 * * page 7, line 6 - line 11 * * page 8, line 1 - line 24 *; | [A]EP0377518 (FAULDING F H & CO LTD [AU]) [A] 1-46 * claims 1,3,4,11,12,18,21-27 * * page 8, line 36 - line 40 ** example 1 *; | [A]EP0535841 (EURO CELTIQUE SA [LU]) [A] 1-46 * claims 1,3 * * page 3, line 8 - line 9 * * page 3, line 17 - line 44 *; | [A]WO9310765 (EURO CELTIQUE SA [US]) [A] 1-46 * page 9, line 16 - line 18 * * claim - * * page 9, line 25 - line 31 * * page 12, line 8 - line 14 * * page 13, line 1 - line 4 * * page 13, line 12 - line 21 *; | [A]EP0548448 (EURO CELTIQUE SA [LU]) [A] 1-46 * claims 1,4,6,7,10,15,17,18,22 * |